Spinocerebellar ataxia type 7

Handbook of Clinical Neurology

Volumn 103, Issue , 2012, Pages 475-491

  Martin, Jean Jacques ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961150038     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-51892-7.00030-9     Document Type: Chapter

References (102)

1. Ahn J.K., Seo J.M., Chung H., et al. Anatomical and functional characteristics in atrophic maculopathy associated with spinocerebellar ataxia type 7. Am J Ophthalmol 2005, 139:923-925.
2. Alfano J.E., Berger J.P. Retinitis pigmentosa, ophthalmoplegia, and spastic quadriplegia. Am J Ophthalmol 1957, 43:231-240.
3. Ansorge O., Giunti P., Michalik A., et al. Ataxin-7 aggregation and ubiquitination in infantile SCA7 with 180 CAG repeats. Ann Neurol 2004, 56:448-452.
4. Anttinen A., Nikoskelainen E., Mattila R.J., et al. Familial olivopontocerebellar atrophy with macular degeneration: a separate entity among the olivopontocerebellar atrophies. Acta Neurol Scand 1986, 73:180-190.
5. Bang O.Y., Huh K., Lee P.H., et al. Clinical and neuroradiological features of patients with spinocerebellar ataxias from Korean kindreds. Arch Neurol 2003, 60:1566-1574.
6. Bang O.Y., Lee P.H., Kim S.Y., et al. Pontine atrophy precedes cerebellar degeneration in spinocerebellar ataxia 7: MRI-based volumetric analysis. J Neurol Neurosurg Psychiatry 2004, 75:1452-1456.
7. Basu P., Chattopadhyay B., Gangopadhaya P.K., et al. Analysis of CAG repeats in SCA1, SCA2, SCA3, SCA6, SCA7 and DRPLA loci in spinocerebellar ataxia patients and distribution of CAG repeats at the SCA1, SCA2 and SCA6 loci in nine ethnic populations of eastern India. Hum Genet 2000, 106:597-604.
8. Benomar A., Krols L., Stevanin G., et al. The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12-p21.1. Nat Genet 1995, 10:84-88.
9. Benton C.S., de Silva R., Rutledge S.L., et al. Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype. Neurology 1998, 51:1081-1086.
10. Bjork A., Lindblom U., Wadensten L. Retinal degeneration in hereditary ataxia. J Neurol Neurosurg Psychiatry 1956, 19:186-193.
11. Bowman A.B., Yoo S.Y., Dantuma N.P., et al. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum Mol Genet 2005, 14:679-691.
12. Brusco A., Gellera C., Cagnoli C., et al. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol 2004, 61:727-733.
13. Cancel G., Duyckaerts C., Holmberg M., et al. Distribution of ataxin-7 in normal human brain and retina. Brain 2000, 123:2519-2530.
14. Cooles P., Michaud R., Best P.V. A dominantly inherited progressive disease in a black family characterized by cerebellar and retinal degeneration, external ophthalmoplegia and abnormal mitochondria. J Neurol Sci 1988, 87:275-288.
15. David G., Giunti P., Abbas N., et al. The gene for autosomal dominant cerebellar ataxia type II is located in a 5-cm region in 3p12-p13: genetic and physical mapping of the SCA7 locus. Am J Hum Genet 1996, 59:1328-1336.
16. David G., Abbas N., Stevanin G., et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet 1997, 17:65-70.
17. David G., Durr A., Stevanin G., et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum Mol Genet 1998, 7:165-170.
18. Del-Favero J., Krols M.A., et al. Molecular genetic analysis of autosomal dominant cerebellar ataxia with retinal degeneration (ADCA type II) caused by CAG triplet repeat expansion. Hum Mol Genet 1998, 7:177-186.
19. Enevoldson T.P., Sanders M.D., Harding A.E. Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy: a clinical and genetic study of eight families. Brain 1994, 117:445-460.
20. Everett C.M., Wood N.W. Trinucleotide repeats and neurodegenerative disease. Brain 2004, 127:2385-2405.
21. Filla A., Mariotti C., Caruso G., et al. Relative frequencies of CAG expansions in spinocerebellar ataxia and dentatorubropallidoluysian atrophy in 116 Italian families. Eur Neurol 2000, 44:31-36.
22. Forsgren L., Libelius R., Holmberg M., et al. Muscle morphology and mitochondrial investigations of a family with autosomal dominant cerebellar ataxia and retinal degeneration mapped to chromosome 3p12-p21.1. J Neurol Sci 1996, 144:91-98.
23. Foster J.B., Ingram T.T.S. Familial cerebro-macular degeneration and ataxia. J Neurol Neurosurg Psychiatry 1962, 25:63-68.
24. Froment J., Bonnet P., Colrat A. Hérédo-dégénérations rétinienne et spino-cérébelleuse: variantes ophtalmoscopiques et neurologiques présentées par trois générations successives. J Med Lyon 1937, 18:153-162.
25. Garden G.A., Libby R.T., Fu Y.H., et al. Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous Purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice. J Neurosci 2002, 22:4897-4905.
26. Giunti P., Stevanin G., Worth P.F., et al. Molecular and genetic study of 18 families with ADCA type 2: evidence for genetic heterogeneity and de novo mutation. Am J Hum Genet 1999, 64:1594-1603.
27. Gouw L.G., Digre K.B., Harris C.P., et al. Autosomal dominant cerebellar ataxia with retinal degeneration: clinical, neuropathologic and genetic analysis of a large kindred. Neurology 1994, 44:1441-1447.
28. Gouw L.G., Kaplan C.D., Haines J.H., et al. Retinal degeneration characterizes a spinocerebellar ataxia mapping to chromosome 3p. Nat Genet 1995, 10:89-93.
29. Gouw L.G., Castaneda M.A., McKenna C.K., et al. Analysis of the dynamic mutation in the SCA7 gene shows marked parental effects on CAG repeat transmission. Hum Mol Genet 1998, 7:525-532.
30. Graham J.G., Oppenheimer D.R. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969, 32:28-34.
31. Greenfield J.G. The Spinocerebellar Degenerations 1954, Blackwell, Oxford.
32. Gu W., Wanh Y., Liu X., et al. Molecular and clinical study of spinocerebellar ataxia type 7 in Chinese kindreds. Arch Neurol 2000, 57:1513-1518.
33. Gunawerdena S., Goldstein L.S.B. Polyglutamine diseases and transport problems. Arch Neurol 2005, 62:46-51.
34. Halsey J.H., Scott T.R., Farmer T.W. Adult hereditary cerebelloretinal degeneration. Neurology 1967, 17:87-90.
35. Harding A.E. The clinical features and classification of the late onset autosomal dominant cerebellar ataxias: a study of 11 families, including descendants of "the Drew family of Walworth" Brain 1982, 105:1-28.
36. Harding A.E. The Hereditary Ataxias and Related Disorders 1984, Churchill Livingstone, Edinburgh.
37. Havener W.H. Cerebellar-macular abiotrophy. Arch Ophthal 1951, 45:40-43.
38. Helmlinger D., Bonnet J., Mandel J.L., et al. Hsp70 and Hsp40 chaperones do not modulate retinal phenotype in SCA7 mice. J Biol Chem 2004, 279:55969-55977.
39. Helmlinger D., Hardy S., Sasorith S., et al. Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes. Hum Mol Genet 2004, 13:1257-1265.
40. Holmberg M., Johansson J., Forsgren L., et al. Localization of autosomal dominant cerebellar ataxia associated with retinal degeneration and anticipation to chromosome 3p12-p21.1. Hum Mol Genet 1995, 4:1441-1445.
41. Holmberg M., Duyckaerts C., Dürr, et al. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet 1998, 7:913-918.
42. Hsieh M., Lin S.J., Chen J.F., et al. Identification of the spinocerebellar ataxia type 7 mutation in Taiwan: application of PCR-based Southern blot. J Neurol 2000, 247:623-629.
43. Jampel R.S., Okazaki H., Bernstein H. Ophthalmoplegia and retinal degeneration associated with spinocerebellar ataxia. Arch Ophthal 1961, 66:247-259.
44. Jardim L.B., Silveira I., Pereira M.L., et al. A survey of spinocerebellar ataxia in South Brazil - 66 new cases with Machado-Joseph disease, SCA7, SCA8, or unidentified disease-causing mutations. J Neurol 2001, 248:870-876.
45. Johansson J., Forsgren L., Sandgren O., et al. Expanded CAG repeats in Swedish spinocerebellar ataxia type 7 (SCA7) patients: effect of CAG repeat length on the clinical manifestation. Hum Mol Genet 1998, 7:171-176.
46. Jöbsis G.J., Weber J.W., Barth P.G., et al. Autosomal dominant cerebellar ataxia with retinal degeneration (ADCA II): clinical and neuropathological findings in two pedigrees and genetic linkage to 3p12-p21.1. J Neurol Neurosurg Psychiatry 1997, 62:367-371.
47. Juvonen V., Hietala M., Kairisto V., et al. The occurrence of dominant spinocerebellar ataxias among 251 Finnish ataxia patients and the role of predisposing large normal alleles in a genetically isolated population. Acta Neurol Scand 2005, 111:154-162.
48. Kaytor M.D., Duvick L.A., Skinner P.J., et al. Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7. Hum Mol Genet 1999, 8:1657-1664.
49. Kim J.Y., Park S.S., Joo S.I., et al. Molecular analysis of spinocerebellar ataxias in Koreans: frequencies and reference ranges of SCA1, SCA2, SCA3, SCA6 and SCA7. Mol Cells 2001, 12:336-341.
50. Kim B.C., Kim M.K., Cho K.H., et al. Spinocerebellar ataxia type 7 without retinal degeneration: a case report. J Korean Med Sci 2002, 17:577-579.
51. Krols L., Martin J.J., David G., et al. Refinement of the locus for autosomal dominant cerebellar ataxia type I to chromosome 3p21.1-14.1. Hum Genet 1997, 99:225-232.
52. Lebre A.S., Jamot L., Takahashi J., et al. Ataxin-7 interacts with a Cb1-associated protein that it recruits into neuronal intranuclear inclusions. Hum Mol Genet 2001, 10:1201-1213.
53. Lee W.Y., Jin D.K., Oh M.R., et al. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6 and 7 in Korean patients. Arch Neurol 2003, 60:858-863.
54. Lindblad K., Savontaus M.L., Stevanin G., et al. An expanded CAG repeat sequence in spinocerebellar ataxia type 7. Genome Res 1996, 6:965-971.
55. Lindenberg K.S., Yvert G., Muller K., et al. Expression analysis of ataxin-7 mrna and protein in human brain: evidence for a widespread distribution and focal protein accumulation. Brain Pathol 2000, 10:385-394.
56. McMahon S.J., Pray-Grant M.G., Schieltz D., et al. Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity. Proc Natl Acad Sci U S A 2005, 102:8478-8482.
57. Margolis R.L. The spinocerebellar ataxias: order emerges from chaos. Curr Neurol Neurosci Rep 2002, 2:447-456.
58. Martin J.J., Van Regemorter N., Krols L., et al. On an autosomal dominant form of retino-cerebellar degeneration: an autopsy study of five patients in one family. Acta Neuropathol (Berl) 1994, 88:277-286.
59. Martin J.J., Van Regemorter N., Del-Favero J., et al. Spinocerebellar ataxia type 7 (SCA7) - correlations between phenotype and genotype in one large Belgian family. J Neurol Sci 1999, 168:37-46.
60. Maruyama H., Izumi Y., Morino H., et al. Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1, 286 Japanese patients. Am J Med Genet 2002, 114:578-583.
61. Matilla A., Gorbea C., Einum D.D., et al. Association of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex. Hum Mol Genet 2001, 10:2821-2831.
62. Mauger C., Del-Favero J., Ceuterick C., et al. Identification and localization of ataxin-7 in brain and retina of a patient with cerebellar ataxia type II using anti-peptide antibody. Brain Res Mol Brain Res 1999, 74:35-43.
63. Michalik A. Molecular genetic and functional analysis of spinocerebellar ataxia type 7 and related polyglutamine disorders 2003, Antwerp, PhD Thesis.
64. Michalik A., van Broeckhoven C. Pathogenesis of polyglutamine disorders: aggregation revisited. Hum Mol Genet 2003, 12:R173-R186.
65. Michalik A., Del-Favero J., Mauger C., et al. Genomic organisation of the spinocerebellar ataxia type 7 (SCA7) gene responsible for autosomal dominant cerebellar ataxia with retinal degeneration. Hum Genet 1999, 105:410-417.
66. Michalik A., Martin J.J., Van Broeckhoven C. Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy. Eur J Hum Genet 2004, 12:2-15.
67. Mittal U., Roy S., Jain S., et al. Post-zygotic de novo trinucleotide repeat expansion at spinocerebellar ataxia type 7 locus: evidence from an Indian family. J Hum Genet 2005, 50:155-157.
68. Monckton D.G., Cayuela M.L., Gould F.K., et al. Very large (CAG)(n) DNA repeat expansions in the sperm of two spinocerebellar ataxia type 7 males. Hum Mol Genet 1999, 8:2473-2478.
69. Moseley M.L., Benzow K.A., Schut L.J., et al. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology 1998, 51:1666-1671.
70. Mushegian A.R., Vishnivetskiy S.A., Gurevich V.V. Conserved phosphoprotein interaction motif is functionally interchangeable between ataxin-7 and arrestins. Biochemistry 2000, 39:6809-6813.
71. Nardacchione A., Orsi L., Brusco A., et al. Definition of the smallest pathological CAG expansion in SCA7. Clin Genet 1999, 56:232-234.
72. Neetens A., Martin J.J., Libert J., et al. Autosomal dominant cone dystrophy - cerebellar atrophy (ADCoCA) (modified ADCA Harding II). Neuroophthalmology 1990, 10:261-275.
73. Palhan V.B., Chen S., Peng G.H., et al. Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. Proc Natl Acad Sci U S A 2005, 102:8472-8477.
74. Pujana M.A., Corral J., Gratacos M., et al. Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group. Hum Genet 1999, 104:516-522.
75. Rüb U., Brunt E.R., Gierga K., et al. Spinocerebellar ataxia type 7 (SCA7): first report of a systematic neuropathological study of a brain of a patient with a very short expanded CAG repeat. Brain Pathol 2005, 15:287-295.
76. Sasaki H., Yabe I., Yamashita I., et al. Prevalence of triplet repeat expansion in ataxia patients from Hokkaido, the northernmost island of Japan. J Neurol Sci 2000, 175:45-51.
77. Schöls L., Bauer P., Schmidt T., et al. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004, 3:291-304.
78. Sherman M.Y., Goldberg A.L. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 2001, 29:15-32.
79. Shimizu Y., Yoshida K., Okano T., et al. Regional features of autosomal-dominant cerebellar ataxia in Nagano: clinical and molecular genetic analysis of 86 families. J Hum Genet 2004, 49:610-616.
80. Silveira I., Miranda C., Guimaraes L., et al. Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus. Arch Neurol 2002, 59:623-629.
81. Soong B.W., Lu Y.C., Choo K.B., et al. Frequency analysis of autosomal dominant cerebellar ataxias in Taiwanese patients and clinical and molecular characterization of spinocerebellar ataxia type 6. Arch Neurol 2001, 58:1105-1109.
82. Stevanin G., Giunti P., David G., et al. De novo expansion of intermediate alleles in spinocerebellar ataxia type 7. Hum Mol Genet 1998, 7:1809-1813.
83. Stevanin G., David G., Durr A., et al. Multiple origins of the spinocerebellar ataxia 7 (SCA7) mutation revealed by linkage disequilibrium studies with closely flanking markers, including an intragenic polymorphism (G3145TG/A3145TG). Eur J Hum Genet 1999, 7:889-896.
84. Storey E., du Sart D., Shaw J.H., et al. Frequency of spinocerebellar ataxia types 1, 2, 3, 5, and 7 in Australian patients with spinocerebellar ataxia. Am J Med Genet 2000, 95:351-357.
85. Strom A.L., Forsgren L., Holmberg M. A role for both wild-type and expanded ataxin-7 in transcriptional regulation. Neurobiol Dis 2005, 20:646-655.
86. Takahashi J., Fujigasaki H., Zander C., et al. Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content. Brain 2002, 125:1534-1543.
87. Tang B., Liu C., Shen L., et al. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol 2000, 57:540-544.
88. Tarlac V., Storey E. Role of proteolysis in polyglutamine disorders. J Neurosci Res 2003, 74:406-416.
89. Tsai H.F., Lin S.J., Li C., et al. Decreased expression of Hsp27 and Hsp70 in transformed lymphoblastoid cells from patients with spinocerebellar ataxia type 7. Biochem Biophys Res Commun 2005, 334:1279-1286.
90. Uchihara T., Fujigasaki H., Koyano S., et al. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias - triple-labeling immunofluorescence study. Acta Neuropathol (Berl) 2001, 102:149-152.
91. van de Warrenburg B.P.C., Frenken C.W.G.M., Ausems M.G.E.M., et al. Striking anticipation in spinocerebellar ataxia type 7: the infantile phenotype. J Neurol 2001, 248:911-914.
92. van de Warrenburg B.P.C., Sinke R.J., Verschuuren-Bemelmans C.C., et al. Spinocerebellar ataxias in the Netherlands. Neurology 2002, 58:702-708.
93. van de Warrenburg B.P.C., Notermans N.C., Schelhaas H.J., et al. Peripheral nerve involvement in spinocerebellar ataxias. Arch Neurol 2004, 61:257-261.
94. van de Warrenburg B.P.C., Sinke R.J., Kremer B. Recent advances in hereditary spinocerebellar ataxias. J Neuropathol Exp Neurol 2005, 64:171-180.
95. van de Warrenburg B.P.C., Hendriks H., Dürr A., et al. Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort. Ann Neurol 2005, 57:505-512.
96. Verougstraete C., Toussaint D. Dégénérescence tapéto-rétinienne avec ataxie cérébelleuse: étude clinique chez plusieurs membres d'une même famille. Bull Soc Belge Ophtalmol 1973, 164:285-295.
97. Wang H.L., Yeh T.H., Chou A.H., et al. Polyglutamine-expanded ataxin-7 activates mitochondrial apoptotic pathway of cerebellar neurons by upregulating Bax and downregulating Bcl-x(L). Cell Signal 2006, 18:541-552.
98. Weiner L.P., Konigsmark B.W., Stoll J., et al. Hereditary olivopontocerebellar atrophy with retinal degeneration: report of a family through six generations. Arch Neurol 1967, 16:364-376.
99. Yamada M., Tan C.F., Inenaga C., et al. Sharing of polyglutamine localization by the neuronal nucleus and cytoplasm in CAG-repeat diseases. Neuropathol Appl Neurobiol 2004, 30:665-675.
100. Yvert G., Lindenberg K.S., Picaud S., Landwehrmeyer G.B., et al. Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice. Hum Mol Genet 2000, 9:2491-2506.
101. Yvert G., Lindenberg K.S., Devys D., et al. SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types. Hum Mol Genet 2001, 10:1679-1692.
102. Zander C., Takahashi J., El Hachimi K.H., et al. Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3. Hum Mol Genet 2001, 10:2569-2579.